Synopsis of recent research by authors named "Hitomi Sakai"
- Hitomi Sakai's recent research primarily focuses on the treatment and management of breast cancer, with significant emphasis on hormone receptor-positive and HER2-negative subtypes, exploring both clinical practice guidelines and innovative therapeutic combinations.
- In a systematic literature review and meta-analysis, Sakai identified critical risk factors for recurrence in Japanese patients with early breast cancer, highlighting the need for personalized perioperative therapies based on these factors.
- Additionally, Sakai's studies assess novel therapeutic strategies, including the combination of nivolumab with abemaciclib and endocrine therapy, and the use of probiotics for mitigating treatment-related side effects in patients undergoing abemaciclib treatment.
